Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Tonneke Beijers"'
Autor:
Gerrit D. Slooter, Jan H. Wijsman, Felice N. van Erning, Art Vreugenhil, Maryska L.G. Janssen-Heijnen, Valery E.P.P. Lemmens, Lonneke V. van de Poll-Franse, Tonneke Beijers, Johannes A. Wegdam
Publikováno v:
Clinical Colorectal Cancer, 16(3), 195-203. CIG Media Group, L.P.
Clinical Colorectal Cancer, 16(3), 195-203. Elsevier
Clinical Colorectal Cancer, 16(3), 195-203. Elsevier
The course of neuropathic symptoms among elderly patients with stage III colon cancer treated with CAPOX (capecitabine, oxaliplatin), capecitabine, or no chemotherapy was investigated. A total of 117 patients (76%) selected from the Netherlands Cance
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::08921628484ec368e14f25ef6cb77ddd
https://cris.maastrichtuniversity.nl/en/publications/7d13e086-1fb6-40ff-bc58-5a8304573849
https://cris.maastrichtuniversity.nl/en/publications/7d13e086-1fb6-40ff-bc58-5a8304573849
Publikováno v:
Supportive Care in Cancer, 22(8), 2261-2269. Springer, Cham
Background The objective of this study was to systematically review all available literature concerning chemotherapy-induced peripheral neuropathy (CIPN) and quality of life (QOL) among cancer patients. Methods A computerized search of the literature
Autor:
Gerard Vreugdenhil, Floortje Mols, Tonneke Beijers, Lonneke V. van de Poll-Franse, Corina van den Hurk, Valery E.P.P. Lemmens
Publikováno v:
Journal of Clinical Oncology, 31(21), 2699-2707. AMER SOC CLINICAL ONCOLOGY
Journal of Clinical Oncology, 31(21), 2699-2707. American Society of Clinical Oncology
Journal of Clinical Oncology, 31(21), 2699-2707. American Society of Clinical Oncology
Purpose To gain insight into the prevalence and severity of chemotherapy-induced neuropathy and its influence on health-related quality of life (HRQOL) in a population-based sample of colorectal cancer (CRC) survivors 2 to 11 years after diagnosis. M
Autor:
Tonneke Beijers, G. Vreugdenhil, Catharina G. Faber, L.V. van de Poll-Franse, F. Mols, Vcg Tjan-Heijnen
Publikováno v:
Annals of Oncology. 25:iv198
Aim: Chemotherapy-induced peripheral neuropathy (CIPN) is a dose-limiting side effect of oxaliplatin which can negatively influence quality of life. We aimed to study the influence of cumulative dose, dose schedule and dose reductions of adjuvant oxa